TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.

Timothy Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.